Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Contemporary Clinical Trials Communications|January 19, 2019
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trialKatie Baca-Motes, Alison M Edwards, Jill Waalen, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
European Heart Journal|August 4, 2007
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trialThomas H Wang, Deepak L Bhatt, Keith A A Fox, et al.
Circulation|May 9, 2022
rECHOmmend: An ECG-Based Machine Learning Approach for Identifying Patients at Increased Risk of Undiagnosed Structural Heart Disease Detectable by EchocardiographyAlvaro E Ulloa-Cerna, Linyuan Jing, John M Pfeifer, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
American Heart Journal|May 16, 2016
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trialSteven R Steinhubl, Rajesh R Mehta, Gail S Ebner, et al.
The Lancet. Digital Health|July 26, 2024
Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralised, randomised controlled trialGiorgio Quer, Erin Coughlin, Jorge Villacian, et al.
Circulation|November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trialPierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.
JAMA|April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trialSteven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
Pageof 19